2012 annual financial data

Sarepta Therapeutics, Inc. 2012 Net margin

Sarepta Therapeutics, Inc. 2012 net margin with verified reported values.

Direct answer

Net margin was -324.91%.

Operating income was -29,703,000 USD and net income was -121,287,000 USD.
Operating cash flow was -29,694,000 USD.

Get free Sarepta Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
37,329,000 USD
Operating income
-29,703,000 USD
Net income
-121,287,000 USD
Operating cash flow
-29,694,000 USD